$13.68
At close: Nov 12, 4:00 PM EST
$13.15
-0.53-3.87%
Pre-Market: 4:09 AM EST
Comments
Loading...
MiNK Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:INKT | Benzinga
MiNK Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 14
EPS Estimate
$-0.860
Quarterly Revenue Estimate
–
Annual Revenue
(as of Jun 30)
(as of Jun 30)
–
Analyze the earnings history of MiNK Therapeutics using advanced sorting and filters.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
INKT | MiNK Therapeutics | -$0.50 | -$0.86 | — | — | $0.00 | — | — | — | 11/14/2025 | |
INKT | MiNK Therapeutics | -$0.73 | -$0.55 | -$1.06 | -92.73% | $0.00 | — | $0.00 | — | 08/14/2025 | |
INKT | MiNK Therapeutics | -$1.10 | -$0.61 | -$0.70 | -14.75% | $0.00 | — | $0.00 | — | 05/15/2025 | |
INKT | MiNK Therapeutics | -$1.58 | -$0.50 | -$0.62 | -24.00% | $0.00 | — | $0.00 | — | 03/18/2025 | |
INKT | MiNK Therapeutics | -$1.50 | -$0.80 | -$0.50 | 37.50% | $0.00 | — | $0.00 | — | 11/14/2024 | |
INKT | MiNK Therapeutics | -$1.80 | -$1.00 | -$0.70 | 30.00% | $0.00 | — | $0.00 | — | 08/13/2024 | |
INKT | MiNK Therapeutics | -$1.70 | -$1.50 | -$1.10 | 26.67% | $0.00 | — | $0.00 | — | 05/14/2024 | |
INKT | MiNK Therapeutics | -$2.30 | -$1.50 | -$1.60 | -6.67% | $0.00 | — | $0.00 | — | 03/21/2024 | |
INKT | MiNK Therapeutics | -$1.90 | -$1.80 | -$1.50 | 16.67% | $0.00 | — | $0.00 | — | 11/09/2023 | |
INKT | MiNK Therapeutics | -$1.80 | -$2.00 | -$1.80 | 10.00% | $0.00 | — | $0.00 | — | 08/10/2023 | |
INKT | MiNK Therapeutics | -$2.30 | -$2.40 | -$1.70 | 29.17% | $0.00 | — | $0.00 | — | 05/11/2023 | |
INKT | MiNK Therapeutics | -$1.80 | -$2.10 | -$2.30 | -9.52% | $0.00 | — | $0.00 | — | 03/21/2023 | |
INKT | MiNK Therapeutics | -$5.90 | -$2.30 | -$1.90 | 17.39% | $0.00 | — | $0.00 | — | 11/03/2022 | |
INKT | MiNK Therapeutics | -$2.60 | -$2.40 | -$1.80 | 25.00% | $0.00 | — | $0.00 | — | 08/09/2022 | |
INKT | MiNK Therapeutics | -$1.60 | -$2.10 | -$2.30 | -9.52% | $0.00 | — | $0.00 | — | 05/10/2022 | |
INKT | MiNK Therapeutics | -$0.60 | — | -$1.80 | — | $0.00 | — | $0.00 | — | 03/18/2022 |
MiNK Therapeutics (INKT) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | 2025-08-14 | $-1.06 | $-0.55 | -92.7 % |
| Q1 | 2025-05-15 | $-0.70 | $-0.61 | -14.8 % |
| Q4 | 2025-03-18 | $-0.62 | $-0.50 | -24.0 % |
| Q3 | 2024-11-14 | $-0.50 | $-0.80 | 37.5 % |
MiNK Therapeutics (INKT) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is MiNK Therapeutics (NASDAQ:INKT) reporting earnings?
MiNK Therapeutics (INKT) is scheduled to report earnings on November 14, 2025. The last reported earnings were for reported on August 14, 2025 for Q2.
What were the latest earnings per share (EPS) for MiNK Therapeutics (NASDAQ:INKT)?
The Actual EPS was $-1.06, which missed the estimate of $-0.55.
What were MiNK Therapeutics’s (NASDAQ:INKT) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.
